|
|
SPECT |
PET |
|
Spatial resolution |
2-3mm |
5-10mm |
|
Radiation dose |
5mSv |
10mSv |
|
Isotope |
99Tcm-HMPAO (Ceretec) 99Tcm ECD (Neurolite) |
18F-fluoro-deoxyglucose (FDG) |
|
T1/2 |
ECD 6hours HMPAO 4hours |
110 min |
|
Radiation |
Gamma rays |
Positron – annihilates with electron and emits two photons at 180deg to each other |
|
|
|
|
|
Method |
Isotope is distributed with blood flow and is fixed on first pass Stays fixed for 12-24 hours Gamma camera rotates around patient at 6deg intervals in various planes to map slices of gamma radiation |
FDG distributes with glucose utilisation Fixed ring detects two matching photons to work out point of decay |
|
Advantages |
Allows ictal imaging Longer half life makes it more accessible and cheaper |
Better spatial resolution |
|
Disadvantages |
Poor spatial resolution Blood flow not glucose metabolism? |
Expensive |
|
|
|
|
SPECT agents:
99Tcm-HMPAO (Ceretec)
• Image within 2- 4hours
• Gets
trapped in cell by conversion to hydrophilic form
99Tcm ECD (Neurolite)
• Faster excretion – better background
• Image within 4 hours (25% cleared by 4hour hours)
Thallium 201 – crosses if BBB abnormal – e.g. tumour
Iodine 123 – PIB scanning for PD
Use of PET and SPECT in epilepsy
• Desai et al Epilepsia 2013
• 53 patients
• Focus localised in 45
• PET co-localised in 25 (56% sensitivity)
• SPECT co-localised in 39 (87% sensitivity)
• If Intracranial EEG and PET disagreed – SPECT co-localised with EEG in 16(80%)
• If intracranial EEG and SPECT disagreed – PET co-localised with EEG in 2(33%)
• No significant effect of imaging concordance on seizure outcome
• 64% had excellent surgical outcome
Other statistics:
PET
• Sensitivity
o TLE 70-90%
o Extra TLE 30-60%
o MRI negative TLE 66%
o Cortical dysplasia 81%